These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 21794814)

  • 1. [How does one manage patients with rheumatoid arthritis and positive serology to hepatitis B, hepatitis C, human immunodeficiency virus?].
    Cabrera Villalba SR; Victoria Hernández Miguel M; Sanmartí Sala R
    Reumatol Clin; 2011; 7(3):203-7. PubMed ID: 21794814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of viral loads and risk of hepatitis B virus reactivation in hepatitis B core antibody-positive rheumatoid arthritis patients undergoing anti-tumour necrosis factor alpha therapy.
    Lan JL; Chen YM; Hsieh TY; Chen YH; Hsieh CW; Chen DY; Yang SS
    Ann Rheum Dis; 2011 Oct; 70(10):1719-25. PubMed ID: 21719446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term course of chronic hepatitis B and C under treatment with etanercept associated with different disease modifying antirheumatic drugs without antiviral prophylaxis.
    Cansu DU; Kalifoglu T; Korkmaz C
    J Rheumatol; 2008 Mar; 35(3):421-4. PubMed ID: 18203328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor necrosis factor-α antagonist therapy for concomitant rheumatoid arthritis and hepatitis C virus infection: a case series study.
    Lin KM; Cheng TT; Lin JC; Chen CJ
    Clin Rheumatol; 2015 Jun; 34(6):1039-46. PubMed ID: 25939523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The pulmonological manifestations of rheumatoid arthritis].
    Bernscherer G; Karabélyos C; Tarján Z
    Orv Hetil; 2008 Jul; 149(29):1355-61. PubMed ID: 18617467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of disease-modifying antirheumatic drug co-therapy with methotrexate and leflunomide in rituximab-treated rheumatoid arthritis patients: results of a 1-year follow-up study from the CERERRA collaboration.
    Chatzidionysiou K; Lie E; Nasonov E; Lukina G; Hetland ML; Tarp U; van Riel PL; Nordström DC; Gomez-Reino J; Pavelka K; Tomsic M; Kvien TK; van Vollenhoven RF; Gabay C
    Ann Rheum Dis; 2012 Mar; 71(3):374-7. PubMed ID: 21972242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate versus leflunomide in rheumatoid arthritis: what is new in 2011?
    Singer O; Gibofsky A
    Curr Opin Rheumatol; 2011 May; 23(3):288-92. PubMed ID: 21378570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of infliximab in a patient with rheumatoid arthritis and chronic hepatitis B.
    Doubrawa E; Ricca RA; Malucelli TO; Pizzol VI; Barros DH; Paiva ES
    Rev Bras Reumatol; 2012 Aug; 52(4):653-5. PubMed ID: 22885430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative effectiveness of tumour necrosis factor alpha inhibitors in combination with either methotrexate or leflunomide.
    Strangfeld A; Hierse F; Kekow J; von Hinueber U; Tony HP; Dockhorn R; Listing J; Zink A
    Ann Rheum Dis; 2009 Dec; 68(12):1856-62. PubMed ID: 19126559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Update 2011: leflunomide in rheumatoid arthritis - strengths and weaknesses.
    Behrens F; Koehm M; Burkhardt H
    Curr Opin Rheumatol; 2011 May; 23(3):282-7. PubMed ID: 21427581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML; Diallo S; Mbengue M; Moreira-Diop T
    Sante; 2001; 11(3):195-200. PubMed ID: 11641084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tocilizumab: new drug. Rheumatoid arthritis: another 'mab', no therapeutic advantage.
    Prescrire Int; 2009 Oct; 18(103):198-201. PubMed ID: 19882783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effectiveness of rituximab in combination with either methotrexate or leflunomide in the treatment of rheumatoid arthritis.
    Narváez J; Díaz-Torné C; Ruiz JM; Hernández MV; Torrente-Segarra V; Ros S; Rodriguez de la Serna A; Díaz-López C; Sanmartí R; Nolla JM
    Semin Arthritis Rheum; 2011 Dec; 41(3):401-5. PubMed ID: 21862107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lung involvement and drug-induced lung disease in patients with rheumatoid arthritis.
    Atzeni F; Boiardi L; Sallì S; Benucci M; Sarzi-Puttini P
    Expert Rev Clin Immunol; 2013 Jul; 9(7):649-57. PubMed ID: 23899235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term safety of anti-TNF treatment in patients with rheumatic diseases and chronic or resolved hepatitis B virus infection.
    Vassilopoulos D; Apostolopoulou A; Hadziyannis E; Papatheodoridis GV; Manolakopoulos S; Koskinas J; Manesis EK; Archimandritis AI
    Ann Rheum Dis; 2010 Jul; 69(7):1352-5. PubMed ID: 20472596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The long-term effects of anti-TNF-α agents on patients with chronic viral hepatitis C and B infections.
    Temel T; Cansu DÜ; Korkmaz C; Kaşifoğlu T; Özakyol A
    Int J Rheum Dis; 2015 Jan; 18(1):40-5. PubMed ID: 25195983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
    Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
    Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of leflunomide 100mg weekly compared to low dose methotrexate in patients with active rheumatoid arthritis. Double blind, randomized clinical trial.
    Jaimes-Hernández J; Meléndez-Mercado CI; Mendoza-Fuentes A; Aranda-Pereira P; Castañeda-Hernández G
    Reumatol Clin; 2012; 8(5):243-9. PubMed ID: 22763150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of safety profiles of tumour necrosis factor α inhibitors and rituximab therapy in patients with rheumatoid arthritis and chronic hepatitis C.
    Chen YM; Chen HH; Chen YH; Hsieh TY; Hsieh CW; Hung WT; Lan JL; Chen DY
    Ann Rheum Dis; 2015 Mar; 74(3):626-7. PubMed ID: 25452310
    [No Abstract]   [Full Text] [Related]  

  • 20. Safety of biological therapies following rituximab treatment in rheumatoid arthritis patients.
    Genovese MC; Breedveld FC; Emery P; Cohen S; Keystone E; Matteson EL; Baptiste Y; Chai A; Burke L; Reiss W; Sweetser M; Shaw TM
    Ann Rheum Dis; 2009 Dec; 68(12):1894-7. PubMed ID: 19155233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.